Day's Low
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.42 % |
3 Month Return | -11.45 % |
1 Year Return | -6.58 % |
Market Stats | |
Previous Close | ₹24.50 |
Open | ₹24.99 |
Volume | 9,208.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹122.75Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹122.75 Cr |
P/B Ratio | 1.14 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹122.75 Cr | 7.61% | 0.59 | NA | NA | |
NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
Organisation | Lasa Supergenerics Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Lasa Supergenerics Ltd
Lasa Supergenerics Ltd. has successfully settled a financial dispute with Bank of Baroda, leading to the withdrawal of an insolvency application. This resolution, recognized by the NCLT, enhances the company's financial stability and allows it to focus on strategic growth and market expansion.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.01% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 187.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.65% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 69.2%
Retail Holding Down
Retail Investor have decreased holdings from 46.35% to 46.34% in Sep 2024 quarter
Price Dip
In the last 3 years, LASA stock has moved down by -58.6%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 53.65% | 0.00 | |
Foreign Institutions | 0.01% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 46.34% | ||
Others | 0% | 0.00 |
Lasa Supergenerics Ltd’s net profit fell -16050% since last year same period to ₹-3.23Cr in the Q2 2024-2025. On a quarterly growth basis, Lasa Supergenerics Ltd has generated -18.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2022, Lasa Supergenerics Ltd has declared dividend of ₹0.25 - translating a dividend yield of 2%.
Read More about DividendsBearish
Neutral
Bullish
Lasa Supergenerics Ltd is currently in a Bearish trading position according to technical analysis indicators.
Lasa Supergenerics Ltd (LASA) share price today is ₹24.99
Lasa Supergenerics Ltd is listed on NSE
Lasa Supergenerics Ltd is listed on BSE
Today’s traded volume of Lasa Supergenerics Ltd(LASA) is 9,208.00.
Today’s market capitalisation of Lasa Supergenerics Ltd(LASA) is ₹122.75Cr.
Lasa Supergenerics Ltd(LASA | Price |
---|---|
52 Week High | ₹41.2 |
52 Week Low | ₹19 |
Lasa Supergenerics Ltd(LASA) share price is ₹24.99. It is down -39.34% from its 52 Week High price of ₹41.2
Lasa Supergenerics Ltd(LASA) share price is ₹24.99. It is up 31.53% from its 52 Week Low price of ₹19
Lasa Supergenerics Ltd(LASA | Returns |
---|---|
1 Day Returns | 0.49% |
1 Month Returns | -2.42% |
3 Month Returns | -11.45% |
1 Year Returns | -6.58% |